Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
North Reef Capital Management LP FFWM First Foundation Inc. 13G/A 7.13% 6mo
TENOR CAPITAL MANAGEMENT Co., L.P. VCIC Vine Hill Capital Investment Corp. 13G/A 0% 6mo
D1 Capital Partners L.P. CLH Clean Harbors Inc 13G/A 2.5% 6mo
WELLINGTON MANAGEMENT GROUP LLP PPG Ppg Industries Inc 13G/A 4.6% 6mo
Dirk Wallinger YSS York Space Systems Inc. 13G 8.6% 6mo
T. Rowe Price Investment Management, Inc. MTSI MACOM Technology Solutions Holdings, Inc. 13G/A 6% 6mo
Empyrean Capital Partners, LP KBON Karbon Capital Partners Corp. 13G/A 9.18% 6mo
BAKER BROS. ADVISORS LP PRAX Praxis Precision Medicines, Inc. 13G 6.3% 6mo
Fourthstone LLC WRIV White River Bancshares Co 13G/A 9.75% 6mo
MAK Capital Fund LP AUTL Autolus Therapeutics plc 13G/A 12.6% 6mo
WELLINGTON MANAGEMENT GROUP LLP OGS ONE Gas, Inc. 13G/A 4.2% 6mo
RA CAPITAL MANAGEMENT, L.P. FDMT 4D Molecular Therapeutics, Inc. 13G/A 9.9% 6mo
ATW Growth Opportunities SPV, LLC FLD Fold Holdings, Inc. 13G/A 3.3% 6mo
CVI Investments, Inc. LAES SEALSQ Corp 13G/A 9.9% 6mo
MMCAP International Inc. SPC ASTL Algoma Steel Group Inc. 13G/A 12.2% 6mo
METEORA CAPITAL, LLC CEPO Cantor Equity Partners I, Inc. 13G/A 14.39% 6mo
Vestal Point Capital, LP TSHA Taysha Gene Therapies, Inc. 13G/A 6.3% 6mo
BIOTECHNOLOGY VALUE FUND L P FHTX Foghorn Therapeutics Inc. 13G/A 9.99% 6mo
Fort Baker Capital Management LP OACC Oaktree Acquisition Corp. III Life Sciences 13G 5.1% 6mo
Point72 Asset Management, L.P. IMNM Immunome Inc. 13G/A 0% 6mo
BIOTECHNOLOGY VALUE FUND L P ELDN Eledon Pharmaceuticals, Inc. 13G/A 9.99% 6mo
Global X Management CO LLC LEU Centrus Energy Corp 13G/A 6.41% 6mo
Euclidean Capital LLC PMVP PMV Pharmaceuticals, Inc. 13G/A 4.9% 6mo
Deep Track Capital, LP CRMD CorMedix Inc. 13G/A 7.94% 6mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC KIDZ KIDZ AI Inc. 13G/A 2.7% 6mo
T. Rowe Price Investment Management, Inc. MEI Methode Electronics Inc 13G 5.9% 6mo
Point72 Asset Management, L.P. OVID Ovid Therapeutics Inc. 13G/A 1.3% 6mo
Nally Michael GENB Generate Biomedicines, Inc. 13G 5.2% 6mo
GCM Investments GP, LLC CART Maplebear Inc. 13G/A 1.7% 6mo
Commodore Capital LP ELVN Enliven Therapeutics, Inc. 13G/A 7.7% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ MDWD MediWound Ltd. 13G 5.5% 6mo
EdgePoint Investment Group Inc. OR OR Royalties Inc. 13G/A 10.38% 6mo
Divisadero Street Capital Management, LP RSI Rush Street Interactive, Inc. 13G/A 6.2% 6mo
Divesh Makan NTSK Netskope Inc 13G/A 28.7% 6mo
RA CAPITAL MANAGEMENT, L.P. CTNM Contineum Therapeutics, Inc. 13G/A 4% 6mo
VIKING GLOBAL INVESTORS LP FTV Fortive Corp 13G/A 7.1% 6mo
Orbis Investment Management Limited TBBB Bbb Foods Inc 13G/A 9% 6mo
1607 Capital Partners, LLC EVF Eaton Vance Senior Income Trust 13G 5.05% 6mo
Two Seas Capital LP PAVM PAVmed Inc. 13G 9.99% 6mo
Vestal Point Capital, LP IMCR Immunocore Holdings plc 13G 5.5% 6mo
JANUS HENDERSON GROUP PLC GKOS GLAUKOS Corp 13G/A 9.2% 6mo
Polar Asset Management Partners Inc. BCARU D. Boral ARC Acquisition I Corp. 13G/A 1.7% 6mo
WELLINGTON MANAGEMENT GROUP LLP R Ryder System Inc 13G/A 4.4% 6mo
Balyasny Asset Management L.P. CAMP Camp4 Therapeutics Corp 13G 5.07% 6mo
Orbis Investment Management Limited QXO QXO, Inc. 13G/A 10.2% 6mo
VIKING GLOBAL INVESTORS LP SION Sionna Therapeutics, Inc. 13G/A 7.1% 6mo
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. IMAX Imax Corp 13G/A 6.8% 6mo
COHEN & STEERS, INC. CTRE CareTrust REIT, Inc. 13G/A 5.46% 6mo
Woodline Partners LP QNRX Quoin Pharmaceuticals Ltd. 13G/A 4.4% 6mo
VIKING GLOBAL INVESTORS LP RLYB Rallybio Corp 13G/A 9.99% 6mo